Australian Functional Fungi Initiative request for partnership 2023 now open

The Bioplatforms Australia supported Australian Functional Fungi Initiative is now seeking partnerships to create foundational biomolecular data resources to fast-track knowledge and innovation of Australian fungi.

Read more

Launch of the Australian Functional Fungi Initiative

Bioplatforms Australia to support the creation of open access biomolecular data to enhance the identification, knowledge and utilisation of Australian native fungi in both research and industry applications

Read more

Australian health research infrastructure underpins world-first brain cancer collaboration

The NCRIS Health Group will support Australian brain cancer research through Brain Cancer Biobanking Australia’s project to develop an integrated network of research platforms

Read more

The Antibiotic Resistant Pathogens Framework Data Initiative multi-omics resource is now published!

The collaborative consortium took on the challenging task of producing and integrating multi-omics datasets generated from key clinical sepsis pathogens from Australia and globally, to support discovery and translational research to tackle the global challenge in the rise of antimicrobial resistance.

Read more

Annual Report 2022

Bioplatforms is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability available to initiatives of breadth, scale and complexity in a way that is not readily achievable through other mechanisms.

Read more
NCRIS Health Group activities cycle

National research infrastructure working together to improve the health of Australians

Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.

Read more

Bioplatforms proud to support precision medicine cancer PrOSPeCT Trial

Bioplatforms Australia welcomes the recent announcement of the $185 million investment to fast-track treatments for rare and ‘untreatable’ cancers.

Read more

Bioplatforms is seeking innovative ideas to enhance research capability

Bioplatforms Australia is seeking innovative ideas from current and potential future partners to identify opportunities to deepen and enhance the overall capability and capacity of its network.

Read more
Load More